AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283 | -36.8% | 4,040 | -30.4% | 0.03% | -37.8% |
| Q4 2022 | $448 | -99.9% | 5,802 | -37.0% | 0.04% | +9.8% |
| Q3 2022 | $411,000 | +101.5% | 9,210 | +71.1% | 0.04% | +78.3% |
| Q4 2021 | $204,000 | -36.1% | 5,382 | -4.3% | 0.02% | -36.1% |
| Q1 2021 | $319,000 | -22.4% | 5,626 | +12.5% | 0.04% | -41.9% |
| Q2 2020 | $411,000 | +45.7% | 4,999 | +83.2% | 0.06% | +37.8% |
| Q4 2019 | $282,000 | -40.8% | 2,728 | -88.4% | 0.04% | -46.4% |
| Q3 2019 | $476,000 | +632.3% | 23,506 | -11.2% | 0.08% | +740.0% |
| Q1 2018 | $65,000 | – | 26,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |